Biopolym. Cell. 2003; 19(6):548-552.
http://dx.doi.org/10.7124/bc.000682
Bioorganic Chemistry
Antitumor activity among derivatives of the 3-chloro-4-(3-hydroxyanilino) -2,5-dihydropyrrole-2,5-dione
1Tarnavsky S. S., 1Dubinina G. G., 1Golovach S. M., 1Yarmoluk S. M.
  1. Institute of Molecular Biology and Genetics, NAS of Ukraine
    150, Akademika Zabolotnoho Str., Kyiv, Ukraine, 03680

Abstract

Fourteen derivatives of the 3-chloro-4-(3-hydroxyanilino)-2,5-di-hydropyrrole-2,5-dione with various substituents at 1 and 3 positions of maleimide cycle have been synthesized and tested for antitumor activity in vitro. Ten compounds have been selected after pre-screening and tested on 52 human tumor cell lines. It has been revealed that 1 -(2,3-dichlorophenyl)-3-chloro-4-(3-hydroxyanili-no)-2,5-dihydro-1H-2,5-pyrroledione and l-benzyl-3-(3-hydroxy-anilino)-4-phenylsulfanyl-2,5-dihydro-1H-2,5-pyrroledione suppress growth of some cancer cell lines with GI50 < 0.5 ·10–7 M and 10–8 M.
Full text: (PDF, in Ukrainian)

References

[1] Fischer PM, Lane DP. Inhibitors of cyclin-dependent kinases as anti-cancer therapeutics. Curr Med Chem. 2000;7(12):1213-45.
[2] Senderowicz AM. The cell cycle as a target for cancer therapy: basic and clinical findings with the small molecule inhibitors flavopiridol and UCN-01. Oncologist. 2002;7 Suppl 3:12-9.
[3] Bailly C, Qu X, Chaires JB, Colson P, Houssier C, Ohkubo M, Nishimura S, Yoshinari T. Substitution at the F-ring N-imide of the indolocarbazole antitumor drug NB-506 increases the cytotoxicity, DNA binding, and topoisomerase I inhibition activities. J Med Chem. 1999;42(15):2927-35.
[4] Andricopulo AD, Yunes RA, Nunes RJ, Savi AOS, Correa R, Cruz AB, Filho VC. Synthesis and antibacterial activity of cyclic imides: 3,4-dichloromaleimides and 4-substituted 3-chloromaleimides. Quim Nova. 1998; 21(5):573-7.
[5] Tarnavskiy SS, Dubinina GG, Golovach SM, Yarmoluk SM. Search for antitumor activity among derivatives of the 2,5-dihydropyrrole-2,5-dione. Biopolym Cell. 2003; 19(3):287-91.